Beta-Adrenergic Blockers for Chronic Heart Failure
- 1 November 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cardiology in Review
- Vol. 17 (6), 287-292
- https://doi.org/10.1097/crd.0b013e3181bdf63e
Abstract
Systolic dysfunction and heart failure are major public health problems associated with a significant risk of morbidity and mortality. During the past 2 decades, considerable progress has been made in defining the underlying pathophysiology and the appropriate therapies in heart failure. In patients with chronic heart failure (CHF), sustained sympathetic overactivation leads to down-regulation of beta receptors and uncoupling of the receptors from adenylate cyclase. The clear understanding of the pivotal role of sympathetic overactivation in CHF has led to the evaluation of beta- blocker therapy in CHF. A number of large randomized clinical trials have been conducted with a variety of beta-blockers, and although most of them have shown benefit, there have been differing findings with different molecules. beta-blockers are now considered part of the standard therapy for all patients with symptomatic CHF. Despite the strong evidence supporting their use, beta-blockers continue to be underutilized in CHF.Keywords
This publication has 36 references indexed in Scilit:
- β-Blocker Use for the Stages of Heart FailureMayo Clinic Proceedings, 2009
- Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure PatientsJournal of the American College of Cardiology, 2006
- Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failureThe American Journal of Cardiology, 2004
- Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardiumBritish Journal of Pharmacology, 2001
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureThe New England Journal of Medicine, 1996
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsThe New England Journal of Medicine, 1982
- Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.Heart, 1980
- Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.Heart, 1980
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975